title: [Treatment of peritoneal carcinomatosis with pressurized intraperitoneal aerosol chemotherapy].
abstract: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new treatment option in patients with peritoneal carcinomatosis (PC). PIPAC has proven efficacious in the treatment of PC from ovarian, colon and gastric cancer. PIPAC has a favourable profile regarding safety for patients and occupational health aspects. This study reviews the current evidence of PIPAC as a step towards implementation and evaluation in Denmark.
authors.affiliation: martin.graversen@rsyd.dk.
authors.forename: Martin
authors.initials: M
authors.lastname: Graversen
authors.forename: Per
authors.initials: P
authors.lastname: Pfeiffer
authors.forename: Michael Bau
authors.initials: MB
authors.lastname: Mortensen
mesh_terms: D000336:Aerosols / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary; D003110:Colonic Neoplasms / Q000473:pathology; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000473:pathology; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D011312:Pressure; D013274:Stomach Neoplasms / Q000473:pathology
chemical_list: D000336:Aerosols; D000970:Antineoplastic Agents